Spain connects medicine cost-effectiveness unit to economic austerity push
This article was originally published in Scrip
Executive Summary
In what appears to be the most nakedly overt connection between government desires to reduce medicines spending and the assessment of health technology, a new package of austerity measures approved yesterday by Spain's congress will – amongst other moves - include the creation of a new committee that will look at the cost-effectiveness of medicines and healthcare products.